TSCAN THERAPEUTICS INC (TCRX)
US89854M1018 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to TCRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.83. This target is 62.98% above the current price.
TCRX was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TCRX.
In the previous month the buy percentage consensus was at a similar level.
TCRX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-01 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-22 | Wedbush | Initiate | Outperform |
| 2023-05-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-05-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-16 | HC Wainwright & Co. | Initiate | Buy |
| 2021-08-13 | Cowen & Co. | Initiate | Outperform |
| 2021-08-10 | Morgan Stanley | Initiate | Overweight |
| 2021-08-10 | Jefferies | Initiate | Buy |